1.
Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo
by Maldini, Colby R
Nature medicine, 2020-11, Vol.26 (11), p.1776-1787

2.
MOLECULAR INTERACTIONS MEDIATING T CELL ANTIGEN RECOGNITION
by Merwe, P. Anton van der
Annual review of immunology, 2003-04, Vol.21 (1), p.659-684

3.
A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry
by Clayette, Pascal
Nature chemical biology, 2009-10, Vol.5 (10), p.743-748

4.
Molecular architecture of native HIV-1 gp120 trimers
by Subramaniam, Sriram
Nature, 2008-09-04, Vol.455 (7209), p.109-113

5.
Oligoclonal CD8+ T cells play a critical role in the development of hypertension
by Trott, Daniel W
Hypertension (Dallas, Tex. 1979), 2014-11, Vol.64 (5), p.1108-1115

6.
Structure of an unliganded simian immunodeficiency virus gp120 core
by Harrison, Stephen C
Nature, 2005-02-24, Vol.433 (7028), p.834-841

7.
Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection
by Sun, Keer
Nature medicine, 2008-05, Vol.14 (5), p.558-564

8.
Structural definition of a conserved neutralization epitope on HIV-1 gp120
by Van Ryk, Donald
Nature, 2007-02-15, Vol.445 (7129), p.732-737

9.
Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease
by Ling, Eleanor M
The Lancet (British edition), 2004-02-21, Vol.363 (9409), p.608-615

10.
Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles
by Purwar, Mansi
Vaccine, 2018-10-08, Vol.36 (42), p.6345-6353

11.
A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex
by KELLY, Bernard T
Nature, 2008, Vol.456 (7224), p.976-979

12.
Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein...
by Ding, Shilei
AIDS research and human retroviruses, 2017-05-01, Vol.33 (5), p.428-431

13.
Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients with Nonalcoholic Steatohepatitis
by Inzaugarat, María Eugenia
Journal of clinical immunology, 2011-08-17, Vol.31 (6), p.1120-1130

14.
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
by Thio, Chloe L
The Lancet (British edition), 2002-12-14, Vol.360 (9349), p.1921-1926

15.
A live-cell assay to detect antigen-specific CD4 + T cells with diverse cytokine profiles
by Roederer, Mario
Nature medicine, 2005-10, Vol.11 (10), p.1113-1117

16.
T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance
by Belkaid, Yasmine
Nature, 2008-09-11, Vol.455 (7210), p.246-250

17.
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial
by Chua, Joel V
Vaccine, 2021-06-29, Vol.39 (29), p.3879-3891

18.
siRNA-directed inhibition of HIV-1 infection
by Shankar, Premlata
Nature medicine, 2002-07, Vol.8 (7), p.681-686

19.
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
by Hendrickson, Wayne A
Nature (London), 1998-06-18, Vol.393 (6686), p.648-659

20.
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
by Kwong, Peter D
Nature (London), 2002-12-12, Vol.420 (6916), p.678-682
